Researchers link obesity, estrogen use, and increased blood-clotting risk

A research team led by Dr. Rinku Majumder from LSU Health New Orleans has published a groundbreaking study in the Journal of Clinical Investigation showing how obesity and estrogen-based medications (including hormonal therapies and oral contraceptives) act together to dramatically increase the thrombotic risk in premenopausal women.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup